Mikhail Kolmogorov
Investigator
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (18)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Cancer is fundamentally a disease of the genome, characterized by extensive genomic, transcriptomic, and epigenomic alterations. Most current studies predominantly use short-read sequencing, gene panels, or microarrays to explore these alterations; however, these technologies can systematically miss or misrepresent certain types of alterations, especially structural variants, complex rearrangements, and alterations within repetitive regions. Long-read sequencing is rapidly emerging as a transformative technology for cancer research by providing a comprehensive view across the genome, transcriptome, and epigenome, including the ability to detect alterations that previous technologies have overlooked. In this Perspective, we explore the current applications of long-read sequencing for both germline and somatic cancer analysis. We provide an overview of the computational methodologies tailored to long-read data and highlight key discoveries and resources within cancer genomics that were previously inaccessible with prior technologies. We also address future opportunities and persistent challenges, including the experimental and computational requirements needed to scale to larger sample sizes, the hurdles in sequencing and analyzing complex cancer genomes, and opportunities for leveraging machine learning and artificial intelligence technologies for cancer informatics. We further discuss how the telomere-to-telomere genome and the emerging human pangenome could enhance the resolution of cancer genome analysis, potentially revolutionizing early detection and disease monitoring in patients. Finally, we outline strategies for transitioning long-read sequencing from research applications to routine clinical practice.
Year:
2025
The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line and matched normal cells from duodenal and pancreatic tissues. Data for the tumor-normal matched samples comes from seventeen distinct state-of-the-art whole genome measurement technologies, including high depth short and long-read bulk whole genome sequencing (WGS), single cell WGS, Hi-C, and karyotyping. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic variants. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.
Year:
2025
Year:
2025
The chromosome 5p15.33 region, which encodes telomerase reverse transcriptase (TERT), harbors multiple germline variants identified by genome-wide association studies (GWAS) as risk for some cancers but protective for others. Here, we characterize a variable number tandem repeat within TERT intron 6, VNTR6-1 (38-bp repeat unit), and detect a strong link between VNTR6-1 alleles (Short: 24-27 repeats, Long: 40.5-66.5 repeats) and GWAS signals rs2242652 and rs10069690 within TERT intron 4. Bioinformatics analyses reveal that rs10069690-T allele increases intron 4 retention while VNTR6-1-Long allele expands a polymorphic G-quadruplex (G4, 35-113 copies) within intron 6, with both variants contributing to variable TERT expression through alternative splicing and nonsense-mediated decay. In two cell lines, CRISPR/Cas9 deletion of VNTR6-1 increases the ratio of TERT- full-length (FL) to the alternative TERT-β isoform, promoting apoptosis and reducing cell proliferation. In contrast, treatment with G4-stabilizing ligands shifts splicing from TERT-FL to TERT-β isoform, implicating VNTR6-1 as a splicing switch. We associate the functional variants VNTR6-1, rs10069690, and their haplotypes with multi-cancer risk and age-related telomere shortening. By regulating TERT splicing, these variants may contribute to fine-tuning cellular longevity and replicative potential in the context of stress due to tissue-specific endogenous and exogenous exposures, thereby influencing the cancer risk conferred by this locus.
Year:
2025
Objective Variants in PRKN and PINK1 are the leading cause of early‐onset autosomal recessive Parkinson's disease, yet many cases remain genetically unresolved. We previously identified a 7 megabases complex structural variant in a pair of monozygotic twins using Oxford Nanopore Technologies (ONT) long‐read sequencing. This study aims to determine if ONT long‐read sequencing can detect a second variant in other unresolved early‐onset Parkinson's disease (EOPD) cases with 1 heterozygous PRKN or PINK1 variant. Methods ONT long‐read sequencing was performed on EOPD patients with 1 reported PRKN / PINK1 pathogenic variant, with onset age under 50. Positive controls included EOPD patients with 2 known PRKN pathogenic variants. Initial testing involved short‐read targeted panel sequencing for single nucleotide variants and multiplex ligation‐dependent probe amplification for copy number variants. Results A total of 47 patients were studied ( PRKN “one‐variant,” n = 23; PINK1 “one‐variant,” n = 12; PRKN “two‐variants,” n = 12). ONT long‐read sequencing identified a second pathogenic variant in 26% of PRKN “one‐variant” patients (6/23), but none in PINK1 “one‐variant” patients (0/12). Detected variants included 1 complex inversion, 2 structural variant overlaps, and 3 duplications. In the PRKN “two‐variants” group, both variants were identified in all patients (100%, 12/12). Interpretation ONT long‐read sequencing effectively identifies pathogenic structural variants in the PRKN locus missed by conventional methods. It should be considered for unresolved EOPD cases when a second variant is not detected through conventional approaches. ANN NEUROL 2025;97:753–765
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (36)
Mihai Pop
Professor
University of Maryland at College Park
Shloka Negi
University of California, Santa Cruz
Michael Schatz
Bloomberg Distinguished Professor
Johns Hopkins University
Andrea Guarracino
Assistant Professor
Translational Genomics Research Institute
Sonja Scholz
National Institute of Neurological Disorders and Stroke
Claudia Gonzaga-Jauregui
Associate Professor (with Tenure)
National Autonomous University of Mexico
PHILLIP RICHMOND
Research Associate Professor
University of Colorado Boulder
Fritz Sedlazeck
Associate Professor
Baylor College of Medicine
Karen H. Miga
Associate Professor
University of California, Santa Cruz
Heer Mehta
Assistant Professor
Baylor College of Medicine
Xylena Reed
Staff Scientist
National Institute on Aging
Erik Garrison
Associate Professor
University of Tennessee Health Science Center
Gabrielle Lemire
Lecturer
University of Ottawa
Justin Zook
National Institute of Standards and Technology
Mitchell Machiela
Senior Investigator
National Cancer Institute
Winston Timp
Joint Appointment
Johns Hopkins University
Jean Monlong
Permanent Researcher CRCN
INSERM
Oscar Flórez-Vargas
Staff Scientist
National Cancer Institute
Alison Klein
Professor
-
Seth Berger
Associate Professor
Children's National Health System
Evan Eichler
Howard Hughes Medical Institute
Danny Miller
Assistant Professor
University of Washington
Stephen Montgomery
Associate Professor
Stanford University
Hua-Jun He
National Institute of Standards and Technology
Xian Chang
University of California, Santa Cruz
Matthew Loose
Professor
University of Nottingham
Eric Vilain
University of California
Nathanael Olson
National Institute of Standards and Technology
Yue Hao
Research Assistant Professor
Translational Genomics Research Institute
Shahinaz Gadalla
National Institutes of Health
Salem Malikic
Staff Scientist
National Institutes of Health
Jennifer McDaniel
National Institute of Standards and Technology
Harriet Dashnow
Assistant Professor
University of Colorado Anschutz Medical Campus
Zhiyong He
National Institute of Standards and Technology
W. Richard McCombie
Professor
Cold Spring Harbor Laboratory
Anne O'Donnell-Luria
Associate Professor
Boston Children's Hospital
Make your next move.
Prepare your application
Review drafts before you send them.